Literature DB >> 29502269

The IL-10-producing regulatory B cells (B10 cells) and regulatory T cell subsets in neuromyelitis optica spectrum disorder.

Yuan Sun1, Ying Huang1, Wei-Wei Chen1, Juan Jia1, Tao Wei2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29502269     DOI: 10.1007/s10072-018-3303-8

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


× No keyword cloud information.
  12 in total

1.  Circulating regulatory B cell subsets in patients with neuromyelitis optica spectrum disorders.

Authors:  Jinming Han; Li Sun; Zhongkun Wang; Xueli Fan; Lifang Wang; Yang-Yang Song; Jie Zhu; Tao Jin
Journal:  Neurol Sci       Date:  2017-04-07       Impact factor: 3.307

2.  [Proportion and significance of CD1d(hi)CD5⁺CD19⁺ regulatory B cell in peripheral blood of patients with neuromyelitis optica].

Authors:  Fen Yang; Dehui Huang; Chen Cheng; Weiping Wu
Journal:  Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi       Date:  2015-03

Review 3.  Human regulatory B cells in health and disease: therapeutic potential.

Authors:  Claudia Mauri; Madhvi Menon
Journal:  J Clin Invest       Date:  2017-03-01       Impact factor: 14.808

4.  Impaired regulatory function and enhanced intrathecal activation of B cells in neuromyelitis optica: distinct from multiple sclerosis.

Authors:  Chao Quan; Hai Yu; Jian Qiao; Baoguo Xiao; Guixian Zhao; Zhiying Wu; Zhenxin Li; Chuanzhen Lu
Journal:  Mult Scler       Date:  2012-08-03       Impact factor: 6.312

5.  Glucose-regulated protein 78 autoantibody associates with blood-brain barrier disruption in neuromyelitis optica.

Authors:  Fumitaka Shimizu; Kristin L Schaller; Gregory P Owens; Anne C Cotleur; Debra Kellner; Yukio Takeshita; Birgit Obermeier; Thomas J Kryzer; Yasuteru Sano; Takashi Kanda; Vanda A Lennon; Richard M Ransohoff; Jeffrey L Bennett
Journal:  Sci Transl Med       Date:  2017-07-05       Impact factor: 17.956

6.  The IL-10-producing regulatory B cells (B10 cells) and regulatory T cell subsets in neuromyelitis optica spectrum disorder.

Authors:  Eun Bin Cho; Hye-Jin Cho; Jin Myoung Seok; Ju-Hong Min; Eun-Suk Kang; Byoung Joon Kim
Journal:  Neurol Sci       Date:  2018-01-19       Impact factor: 3.307

7.  CNS Aquaporin-4-specific B cells connect with multiple B-cell compartments in neuromyelitis optica spectrum disorder.

Authors:  Markus C Kowarik; David Astling; Christiane Gasperi; Scott Wemlinger; Hannah Schumann; Monika Dzieciatkowska; Alanna M Ritchie; Bernhard Hemmer; Gregory P Owens; Jeffrey L Bennett
Journal:  Ann Clin Transl Neurol       Date:  2017-05-09       Impact factor: 4.511

8.  IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases.

Authors:  Ping Shen; Toralf Roch; Vicky Lampropoulou; Richard A O'Connor; Ulrik Stervbo; Ellen Hilgenberg; Stefanie Ries; Van Duc Dang; Yarúa Jaimes; Capucine Daridon; Rui Li; Luc Jouneau; Pierre Boudinot; Siska Wilantri; Imme Sakwa; Yusei Miyazaki; Melanie D Leech; Rhoanne C McPherson; Stefan Wirtz; Markus Neurath; Kai Hoehlig; Edgar Meinl; Andreas Grützkau; Joachim R Grün; Katharina Horn; Anja A Kühl; Thomas Dörner; Amit Bar-Or; Stefan H E Kaufmann; Stephen M Anderton; Simon Fillatreau
Journal:  Nature       Date:  2014-02-23       Impact factor: 49.962

9.  Interleukin-35 induces regulatory B cells that suppress autoimmune disease.

Authors:  Ren-Xi Wang; Cheng-Rong Yu; Ivy M Dambuza; Rashid M Mahdi; Monika B Dolinska; Yuri V Sergeev; Paul T Wingfield; Sung-Hye Kim; Charles E Egwuagu
Journal:  Nat Med       Date:  2014-04-17       Impact factor: 53.440

Review 10.  Role of regulatory b cells in neuroimmunologic disorders.

Authors:  Jinming Han; Li Sun; Xueli Fan; Zhongkun Wang; Yun Cheng; Jie Zhu; Tao Jin
Journal:  J Neurosci Res       Date:  2016-04-26       Impact factor: 4.164

View more
  1 in total

1.  Frequency of IL-10-producing regulatory B cells associated with disease activity in thyroid-associated orbitopathy.

Authors:  Yun-Gang Ding; Guo Chen; Qian Li; Xiao-Feng Wen; Lai Wei; Hua-Sheng Yang
Journal:  Int J Ophthalmol       Date:  2018-09-18       Impact factor: 1.779

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.